Featured Announcement: Zhongsheng Pharmaceutical's oral anti-coronavirus innovative drug RAY1216 was approved for clinical trial; Tongce Medical acquired 29.75% of Heren Technology
- Post date May 15, 2022 — 19:45 Post Lock
Related Data
Home » News » Featured Announcement: Zhongsheng Pharmaceutical's oral anti-coronavirus innovative drug RAY1216 was approved for clinical trial; Tongce Medical acquired 29.75% of Heren Technology